Diagnostic value of miR-30d-5p and miR-125b-5p in acute myocardial infarction

Jia,Kegang; Shi,Ping; Han,Xuejing; Chen,Tienan; Tang,Hongxia; Wang,Jing

doi:10.3892/mmr.2016.5246

Diagnostic value of miR-30d-5p and miR-125b-5p in acute myocardial infarction

Authors:
- Kegang Jia
- Ping Shi
- Xuejing Han
- Tienan Chen
- Hongxia Tang
- Jing Wang
View Affiliations

Affiliations: Department of Clinical Laboratory, TEDA International Cardiovascular Hospital, Tianjin 300457, P.R. China, Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin 300457, P.R. China
Published online on: May 11, 2016 https://doi.org/10.3892/mmr.2016.5246
Pages: 184-194
Copyright: © Jia et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rapid and accurate differential diagnosis of acute myocardial infarction (AMI) is crucial for timely interventions and the improvement of prognosis. However, this is difficult to achieve using current methods. Therefore, the present study aimed to evaluate the suitability of circulating microRNAs (miRNAs) as AMI biomarkers in patients with acute coronary syndrome (ACS). miRNA profiling in plasma samples from patients with AMI (n=3) and healthy controls (n=3) was performed using microarrays. Results were then validated in five patients and five healthy controls. miRNA-125b-5p and miR-30d-5p expression levels were quantified in plasma samples from 230 patients with ACS and 79 healthy controls using reverse transcription-quantitative polymerase chain reaction. Routine diagnostic parameters were assessed, including creatinine kinase MB, cardiac troponin I (cTnI) and myoglobin. A total of 33 miRNAs were differentially expressed in patients with AMI and healthy controls. Following validation based on the previously established roles for these miRNAs, six miRNAs were validated. miR‑125b‑5p and miR‑30d‑5p were selected for further investigation. Expression levels of miR‑125b‑5p and miR‑30d‑5p in plasma were higher in patients with ACS compared with the healthy controls (P<0.001). Receiver operating characteristic curve analysis revealed that the area under the curve of miR‑30d‑5p was higher than that of cTnI (0.915 and 0.899). miR‑125b‑5p (sensitivity, 0.808; specificity, 0.845) and miR‑30d‑5p (sensitivity, 0.855; specificity, 0.810) were suitable diagnostic predictors of AMI. Kaplan-Meier survival analysis indicated that miR-125b-5p levels were associated with 6 month cardiovascular events in patients with AMI, but not miR‑30d‑5p. miR-125b-5p and miR-30d-5p presented a diagnostic value for early diagnosis of AMI, and miR‑30d‑5p may have a higher diagnostic value than cTnI.

View Figures

View References

1	Kumar A and Cannon CP: Acute coronary syndromes: Diagnosis and management, part I. Mayo Clin Proc. 84:917–938. 2009. View Article : Google Scholar : PubMed/NCBI
2	Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, et al: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction. J Am Coll Cardiol. 50:e1–e157. 2007. View Article : Google Scholar
3	Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, Fesmire FM, Ganiats TG, Lincoff AM, et al: 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update. Circulation. 126:875–910. 2012. View Article : Google Scholar : PubMed/NCBI
4	Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats G, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, et al: 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol. 64:e139–228. 2014. View Article : Google Scholar : PubMed/NCBI
5	Braunwald E: Unstable angina and non-ST elevation myocardial infarction. Am J Respir Crit Care Med. 185:924–932. 2012. View Article : Google Scholar
6	White HD and Chew DP: Acute myocardial infarction. Lancet. 372:570–584. 2008. View Article : Google Scholar : PubMed/NCBI
7	Chieffo A, Buchanan GL, Mauri F, Mehilli J, Vaquerizo B, Moynagh A, Mehran R and Morice MC: ACS and STEMI treatment: Gender-related issues. EuroIntervention. 8(Suppl P): P27–P35. 2012. View Article : Google Scholar : PubMed/NCBI
8	Bellbhudder U and Stanfliet JC: Clinicians ignore best practice guidelines: Prospective audit of cardiac injury marker ordering in patients with chest pain. S Afr Med J. 104:305–306. 2014. View Article : Google Scholar : PubMed/NCBI
9	Ozturk G, Tavil B, Ozguner M, Ginis Z, Erden G, Tunc B, Azik MF, Uckan D and Delibas N: Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation. J Clin Lab Anal. 29:259–262. 2015. View Article : Google Scholar
10	Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M and Katus H: It's time for a change to a troponin standard. Circulation. 102:1216–1220. 2000. View Article : Google Scholar : PubMed/NCBI
11	Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, et al: Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators: A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 361:2538–2547. 2009. View Article : Google Scholar : PubMed/NCBI
12	Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, Gilson G, Corsten MF, Schroen B, Lair ML, Heymans S and Wagner DR: Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem. 58:559–567. 2012. View Article : Google Scholar : PubMed/NCBI
13	Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S, Warnholtz A, Fröhlich M, et al: Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 361:868–877. 2009. View Article : Google Scholar : PubMed/NCBI
14	Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW and Jing Q: Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 31:659–666. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hsu A, Chen SJ, Chang YS, Chen HC and Chu PH: Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction. BioMed Res Int. 2014:4186282014. View Article : Google Scholar : PubMed/NCBI
16	Peng L, Chun-guang Q, Bei-fang L, Xue-zhi D, Zi-hao W, Yun-fu L, Yan-ping D, Yang-gui L, Wei-guo L, Tian-yong H and Zhen-wen H: Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction. Diagn Pathol. 9:892014. View Article : Google Scholar : PubMed/NCBI
17	Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, et al: Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 3:e36942008. View Article : Google Scholar : PubMed/NCBI
18	Hu SJ, Ren G, Liu JL, Zhao ZA, Yu YS, Su RW, Ma XH, Ni H, Lei W and Yang ZM: MicroRNA expression and regulation in mouse uterus during embryo implantation. J Biol Chem. 283:23473–23484. 2008. View Article : Google Scholar : PubMed/NCBI
19	Dweep H and Gretz N: miRWalk2.0: A comprehensive atlas of microRNA-target interactions. Nat Methods. 12:6972015. View Article : Google Scholar : PubMed/NCBI
20	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
21	Fichtlscherer S1, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T and Müller-Ardogan M: et al Circulating microRNAs in patients with coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
22	Kroh EM, Parkin RK, Mitchell PS and Tewari M: Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 50:298–301. 2010. View Article : Google Scholar : PubMed/NCBI
23	Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Just S, Borries A, Rudloff J, Leidinger P, et al: MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol. 106:13–23. 2011. View Article : Google Scholar
24	Bostjancic E, Zidar N and Glavac D: MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers. 27:255–268. 2009. View Article : Google Scholar
25	Iguchi H, Kosaka N and Ochiya T: Secretory microRNAs as a versatile communication tool. Commun Integr Biol. 3:478–481. 2010. View Article : Google Scholar : PubMed/NCBI
26	Zampetaki A, Willeit P, Drozdov I, Kiechl S and Mayr M: Profiling of circulating microRNAs: From single biomarkers to re-wired networks. Cardiovasc Res. 93:555–562. 2012. View Article : Google Scholar :
27	Gidlöf O, Andersson P, van der Pals J, Götberg M and Erlinge D: Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology. 118:217–226. 2011. View Article : Google Scholar : PubMed/NCBI
28	Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
29	Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, et al: Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2:ra812009. View Article : Google Scholar : PubMed/NCBI